NCBS Home page
Accession List
Pathway List
Search
Authorized Users
Help
News archives

Accession Type:
Network
MAPK-bistability
-fig1c
Shared_Object_
MAPK-bistability
-fig1c
Sos
PKC
MAPK
PLA2
Ras
 Molecule
 Enzyme
 Reaction
PDGFR

Enter a Search String

Special character and space not allowed in the query term. Search string should be at least 2 characters long.
Search in: Search for Match By

Parameters for Ras (Pathway Number 184)

Pathway Layout

Pathway Basic Parameters

Pathway NameRas
Pathway Entry Number 184
Accession Number 35
Accession Name MAPK-bistability-fig1c
Species Generic mammalian
Tissue NIH 3T3 Expression
CellCompartmentSurface - Nucleus
Related Pathways 7, 25, 37, 58, 63, 76, 212, 231, 318, 333, 353, 367, 372, 378, 385, 391, 397, 404, 410, 416, 422, 427, 433, 439, 445, 451, 457, 463, 469, 475, 481, 487, 493, 499, 505, 511, 517, 523, 529, 536, 542, 548, 554, 560, 566, 572, 578, 584, 590, 596, 602, 608, 614, 620, 626, 632, 638, 644, 650, 656, 662, 668, 674, 680, 687, 693, 700, 705, 711, 717, 723, 729, 735, 741, 747, 753, 759, 765, 771, 777, 783, 789, 795, 801, 807, 813, 819, 825, 831, 837, 843, 849, 855, 861, 867, 873, 879, 885, 891, 897, 903, 909, 915, 923, 929, 935, 941, 947, 953, 959, 966, 972, 978, 984, 990, 996, 1001, 1007, 1013, 1019, 1025, 1031, 1037, 1043, 1049, 1055, 1061, 1067
Notes The main refs for Ras are Boguski and McCormick Nature 366 643-654 '93 Major review Eccleston et al JBC 268:36 pp 27012-19 Orita et al JBC 268:34 25542-25546

Statistics

6
2
3

Conversion format

This pathway is part of accession 35 and is completely specified in the file acc35.g.
There is no separate files for just this pathway.
FormatFile
Native Format (GENESIS format)    acc35.g   
GENESIS Format (Annotated version)    Anno_acc35.g   
MATLAB format    acc35.m   
SBML format    acc35.xml   


Pathway Detail   Molecule List   Enzyme List   Reaction List  


Database compilation and code copyright (C) 2022, Upinder S. Bhalla and NCBS/TIFR
This Copyright is applied to ensure that the contents of this database remain freely available. Please see FAQ for details.